Not only that, the net operating cash flow for the previous quarter was about the same as the cash they have left. Not great, but was expected.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025